US Patent 11370840 Method of using anti-CD47 antibody molecules
Patent 11370840 was granted and assigned to Ultrahuman Four Limited on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11370840 Method of using anti-CD47 antibody molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
